Chinese DENOVO PD Registry

NCT05767151 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-03-14

No results posted yet for this study

Summary

The main objective of this longitudinal, multi-center study is to explore the clinical characteristics of PD and confirm biomarkers for PD evolution or progression.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • Xiangya Hospital of Central South University

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2031-01-01
Completion
2031-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05767151 on ClinicalTrials.gov